Abstract |
In a randomized, prospective study, single- drug antibiotic therapy with cefoxitin (CFX) was compared to combination therapy with gentamicin and clindamycin (G/C) as definitive treatment for acute colonic diverticulitis. Excluding individuals requiring immediate operation, 51 patients with a clinical diagnosis of diverticulitis, who were hospitalized at five different medical centers, were randomized to receive CFX (30 patients) or G/C (21 patients). Age, sex, and the severity of diverticulitis were similar in the two groups. The cure rates of 90% and 85.7% observed for CFX and G/C, respectively, did not differ significantly. Leukocytosis resolved in a shorter time period in patients treated with CFX than in those treated with G/C (2.5 +/- 0.4 vs 4.1 +/- 0.6 days, respectively) (P = 0.03, Student's t test, unpaired data). Two cases of possibly antibiotic-related toxicity occurred in the CFX group versus three cases in the G/C group. The average cost of a course of CFX therapy was $417 compared with $488 for G/C. In this study, cefoxitin demonstrated efficacy and tolerability similar to that of gentamicin- clindamycin in the treatment of acute colonic diverticulitis and may be preferred in view of its narrower antimicrobial spectrum and lower cost.
|
Authors | J M Kellum, H J Sugerman, G F Coppa, L R Way, R Fine, B Herz, E L Speck, D Jackson, R J Duma |
Journal | Clinical therapeutics
(Clin Ther)
1992 May-Jun
Vol. 14
Issue 3
Pg. 376-84
ISSN: 0149-2918 [Print] United States |
PMID | 1638578
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Gentamicins
- Clindamycin
- Cefoxitin
|
Topics |
- Acute Disease
- Aged
- Cefoxitin
(adverse effects, therapeutic use)
- Clindamycin
(adverse effects, therapeutic use)
- Diverticulitis, Colonic
(drug therapy)
- Drug Costs
- Drug Therapy, Combination
(therapeutic use)
- Female
- Gentamicins
(adverse effects, therapeutic use)
- Humans
- Male
- Middle Aged
- Prospective Studies
|